Medpace Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Net Income	282.81	245.37	181.85	145.38	100.44	73.19	39.12	13.43	-8.67
Depreciation & Amortization	45.97	40.36	37.41	33.45	33.14	38.8	46.47	58.11	69.52
Share-Based Compensation	20.52	21.41	14.47	13.78	20.74	6.5	4.46	9.82	22.32
Other Operating Activities	84.07	80.91	29.6	66.06	47.55	38.1	7.33	10.38	2.7
Operating Cash Flow	433.37	388.05	263.33	258.68	201.87	156.58	97.39	91.73	85.87
Operating Cash Flow Growth	11.68%	47.36%	1.80%	28.14%	28.92%	60.79%	6.16%	6.83%	-
Capital Expenditures	-36.65	-36.88	-28.27	-31.34	-17.91	-16.02	-11.72	-13.54	-6.47
Other Investing Activities	2.02	-1.86	-3.09	0.13	-1.23	-0.95	-0.51	0.12	0.03
Investing Cash Flow	-34.63	-38.74	-31.36	-31.21	-19.14	-16.97	-12.24	-13.42	-6.43
Share Issuance / Repurchase	-132.64	-825.78	-44.45	-82.28	6.52	2.49	-153.77	174.12	0.86
Debt Issued / Paid	-50	50	0	0	-80.44	-142.19	57.63	-227.9	-116.06
Other Financing Activities	-	-	-	-	-	-1.88	-1.68	-4.22	-1.29
Financing Cash Flow	-182.64	-775.78	-44.45	-82.28	-73.92	-141.58	-97.83	-58.01	-116.49
Exchange Rate Effect	1.08	-6.57	-3.97	0.67	-0.17	-1.24	1.77	-0.63	-0.6
Net Cash Flow	217.18	-433.04	183.54	145.85	108.64	-3.21	-10.92	19.67	-37.65
Free Cash Flow	396.73	351.17	235.06	227.34	183.96	140.56	85.66	78.2	79.41
Free Cash Flow Growth	12.97%	49.40%	3.40%	23.58%	30.87%	64.09%	9.55%	-1.52%	-
Free Cash Flow Margin	21.04%	24.05%	20.58%	24.55%	21.37%	19.95%	19.64%	18.55%	22.11%
Free Cash Flow Per Share	12.91	10.84	6.55	6.38	5.13	3.95	2.19	2.19	2.53

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).